Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
TOPLINE:
The likelihood of receiving a dementia diagnosis in older adults varies significantly by region across the United States, a new study suggests. Rates ranged from 1.7% to 5.4%, with variations more pronounced in those aged 66-74 years and Black or Hispanic individuals.
METHODOLOGY:
Researchers analyzed newly diagnosed cases of Alzheimer’s disease and related dementias (ADRD) using the 2018-2019 Medicare claims data for 4.8 million older adults across 306 hospital referral regions (HRRs).
Participants were categorized by age and race or ethnicity to examine variations in diagnosis rates.
Regional characteristics such as education level and prevalence of obesity, smoking, and diabetes were included to adjust for population risk factors.
ADRD-specific diagnostic intensity was calculated as the ratio of the observed-to-expected new cases of ADRD in each HRR.
TAKEAWAY:
Unadjusted analysis for that overall, 3% of older adults received a new ADRD diagnosis in 2019, with rates ranging from 1.7 to 5.4 per 100 individuals across HRRs and varied by age category.
Regions in the South had the highest unadjusted ADRD case concentration, and the areas in the West/Northwest had the lowest.
The ADRD-specific diagnosis intensity was 0.69-1.47 and varied the most in Black and Hispanic individuals and those aged 66-74 years.
Regional differences in ADRD diagnosis rates are not fully explained by population risk factors, indicating potential health system-level differences.
IN PRACTICE:
“From place to place, the likelihood of getting your dementia diagnosed varies, and that may happen because of everything from practice norms for healthcare providers to individual patients’ knowledge and care-seeking behavior. These findings go beyond demographic and population-level differences in risk and indicate that there are health system-level differences that could be targeted and remediated,” lead author said in a press release.
SOURCE:
The study was led by Julie P.W. Bynum, MD, MPH, professor of internal medicine, University of Michigan Medical School, Ann Arbor, Michigan, and published online on August 16, in Alzheimer’s & Dementia.
LIMITATIONS:
The results may not be generalizable to other groups. The observational design of the study cannot completely negate residual confounding. The measures of population risks are coarser than those used in well-characterized epidemiologic studies, leading to potential imprecision. Finally, the study was not designed to determine whether regional differences in the likelihood of ADRD diagnosis resulted in differences in the population health outcomes.
DISCLOSURES:
The study was supported by a grant from the National Institute on Aging. The authors reported no conflicts of interest.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Send comments and news tips to [email protected].